CONCLUSIONS OF THE COUNCIL AND THE MINISTERS FOR HEALTH OF THE MEMBER STATES, MEETING WITHIN THE COUNCIL of 4 June 1991 on the monitoring of action to reduce drug demand (91/C 170/02)

THE COUNCIL OF THE EUROPEAN COMMUNITIES AND THE MINISTERS FOR HEALTH OF THE MEMBER STATES, MEETING WITHIN THE COUNCIL,

Further to their previous resolutions and conclusions and, in particular, their conclusions of 3 December 1990 on reducing demand for narcotic drugs and psychotropic substances (1),

In view of the social and health objectives contained in the European Plan to Combat Drugs, approved by the European Council on 13 and 14 December 1990,

Having noted the proceedings of the ad hoc Working Party on Drug Abuse in accordance with the aforementioned resolutions and conclusions, as requested by the European Committee on the fight against drugs (Celad),

Consider that both the policies implemented by the Member States and the action pursued at Community level with a view to reducing drug demand should be regularly monitored;

Consider that the regular report on actions to reduce drug demand, which the Commission has been requested to draw up in collaboration with the Member

States, should include additional activities by the Commission in this area;

Suggest that the Member States supply appropriate information for the report to show in particular the following social and health aspects:

- prevention strategies and structures,

-type, extent and trend of drug demand and drug addiction,

-strategies and structures for receiving and treating drug addicts,

-strategies and structures for social and occupational rehabilitation of drug addicts

-methods used for assessing these strategies and results obtained,

and, as far as possible, details of the human and financial resources used;

Again stress the need to that end to improve on solid bases the qualitative and quantitative comparability of the data available in order to allow effective monitoring and action at Community level in the field of drug demand reduction;

Express their positive assessment of the first stage of the feasibility study submitted by the Commission on a European Drugs Monitoring Centre and consider that such a Centre would be a useful contribution towards achieving the aformentioned aims.

(1) OJ No C 329, 31. 12. 1990, p. 20.